California Statutes

§ 127691. — 127691. (Amended by Stats. 2023, Ch. 42, Sec. 50.)

California § 127691.
JurisdictionCalifornia
Code HSCHealth and Safety Code - HSC
Div. 107.DIVISION 107. HEALTH CARE ACCESS AND INFORMATION
Part 2.PART 2. HEALTH POLICY AND PLANNING
Ch. 10.CHAPTER 10. California Affordable Drug Manufacturing Act of 2020

This text of California § 127691. (127691. (Amended by Stats. 2023, Ch. 42, Sec. 50.)) is published on Counsel Stack Legal Research, covering California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cal. Health and Safety Code - HSC Code § 127691. (2026).

Text

For purposes of this chapter, the following definitions apply:

(a)“Generic drug” means a drug that is approved pursuant to subdivision (j) of Section 355 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 301 et seq.), or a biosimilar, as defined under the federal Public Health Service Act (42 U.S.C. Sec. 262).
(b)“Partnerships” include, but are not limited to, agreements for the procurement of generic prescription drugs by way of contracts, grant agreements, or purchasing by a payer, state governmental agency, group purchasing organization, nonprofit organization, or other entity.
(c)“California Health and Human Services Agency” or “CHHSA” means the California Health and Human Services Agency, or any of its departments, including the Department of Health Care Access and Inform

Free access — add to your briefcase to read the full text and ask questions with AI

Legislative History

Amended by Stats. 2023, Ch. 42, Sec. 50. (AB 118) Effective July 10, 2023.
View on official source ↗

Cite This Page — Counsel Stack

Bluebook (online)
California § 127691., Counsel Stack Legal Research, https://law.counselstack.com/statute/ca/HSC/127691..